Temporal sequence of incident cigarette, coffee, and alcohol use among AA participants

American Journal of Drug and Alcohol Abuse

Volumn 37, Issue 1, 2011, Pages 27-36

  Reich, Michael S ^a   Dietrich, Mary S ^a   Martin, Peter R ^a  

^a Psychiatric Hospital at Vanderbilt   (United States)

Author keywords

alcohol; Alcoholics Anonymous; cigarette; coffee; gateway drug

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLICS ANONYMOUS; CIGARETTE SMOKING; COFFEE; FEMALE; HUMAN; MALE; QUESTIONNAIRE; REVIEW; TOBACCO DEPENDENCE;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ALCOHOLICS ANONYMOUS; COFFEE; DRINKING; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SMOKING;

EID: 79751510751     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2010.540283     Document Type: Review

References (48)

1. Grant BF, Stinson FS, Dawson DA, Chou P, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Arch Gen Psychiatry 2004; 61: 807-816.
2. Chen CM, Dufour MC, Yi H. Alcohol consumption among young adults ages 18-24 in the United States: results from the 2001-2002 NESARC Survey. Alcohol Res Health 2004; 28(4):269-281.
3. Dawson DA, Goldstein RB, Chou SP, Ruan JW, Grant BF. Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders. Alcohol Clin Exp Res 2008; 32(12):119-123.
4. Kandel D. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. Cambridge: Cambridge University Press, 2002.
5. Torabi M, Bailey W, Majd-Jabbari M. Cigarette smoking as a predictor of alcohol and other drug use by children and ado-lescents: evidence of the "gateway drug effect". J Sch Health 1993; 63(7):302-306.
6. Parra-Medina D, Talavera G, Elder J, Woodruff S. Role of cigarette smoking as a gateway drug to alcohol use in Hispanic junior high school students. J Natl Cancer Inst Monogr 1995; 18:83-86.
7. Grucza RA, Bierut LJ. Cigarette smoking and the risk for alcohol use disorders among adolescent drinkers. Alcohol Clin Exp Res 2006; 30(12):2046-2054. (Pubitemid 44749532)
8. Anthony JC, Echeagaray-Wagner F. Epidemiologic analy-sis of alcohol and tobacco use. Alcohol Res Health 2000; 24(4):201-208.
9. DiFranza JR, Savageau JA, Rigotti NA, Fletcher K, Ockene JK, McNeill AD, Coleman M, Wood C. Development of symptoms of tobacco dependence in youths: 30 month fol-low up data from the DANDY study. Tob Control 2002; 11(3):228-235.
10. Istvan J, Matarazzo JD. Tobacco, alcohol, and caffeine use: a review of their interrelationships. Psychol Bull 1984; 95(2):301-326.
11. Patten CA, Martin JE, Owen N. Can psychiatric and chemi-cal dependency treatment units be smoke free? J Subst Abuse Treat 1996; 13(2):107-118. (Pubitemid 26304250)
12. Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE. Varenicline, an alpha4beta2 nicotinic acetylcholine recep-tor partial agonist, selectively decreases ethanol consump-tion and seeking. Proc Natl Acad Sci USA 2007; 104(30): 12518-12523. (Pubitemid 47206170)
13. NCA. National Coffee Drinking Trends. New York, NY: National Coffee Association of the U.S.A., Inc., 2007.
14. Reich MS, Dietrich MS, Finlayson AJ, Fischer EF, Martin PR. Coffee and cigarette consumption and perceived effects in recovering alcoholics participating in alcoholics anonymous in Nashville, Tennessee, USA. Alcohol Clin Exp Res 2008; 32(10):1799-1806.
15. de Paulis T, Schmidt DE, Bruchey AK, Kirby MT, McDonald MP, Commers P, Lovinger DM, Martin PR. Dicinnamoylquinides in roasted coffee inhibit the human adenosine transporter. Eur J Pharmacol 2002; 442(3): 215-223. (Pubitemid 34626196)
16. de Paulis T, Commers P, Farah A, Zhao J, McDonald MP, Galici R, Martin PR. 4-Caffeoyl-1,5-quinide in roasted coffee inhibits [3H]naloxone binding and reverses anti-nociceptive effects of morphine in mice. Psychopharmacology (Berl) 2004; 176(2):146-153. (Pubitemid 39517944)
17. Collins LM, Graham JW, Rousculp SS, Hansen WB. Heavy caffeine use and the beginning of the substance use onset process: an illustration of latent transition analysis. In The Science of Prevention: Methodological Advances from Alcohol and Substance Abuse Research. Bryant K, Windle M, West S, eds. Washington, DC: American Psychological Association, 1998; 79-99.
18. Bernstein GA, Carroll ME, Thuras PD, Cosgrove KP, Roth ME. Caffeine dependence in teenagers. Drug Alcohol Depend 2002; 66(1):1-6. (Pubitemid 34159249)
19. Flores GB, Andrade F, Lima DR. Can coffee help fighting the drug problem? Preliminary results of a Brazilian youth drug study. Acta Pharmacol Sin 2000; 21(12):1059-1070. (Pubitemid 32012712)
20. Midanik LT, Clark WB. The demographic distribution of US drinking patterns in 1990: description and trends from 1984. Am J Public Health 1994; 84(8):1218-1222. (Pubitemid 24250687)
21. Skinner HA, Sheu WJ. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol 1982; 43(11):1157-1170. (Pubitemid 13082703)
22. Russell M, Marshall JR, Trevisan M, Freudenheim JL, Chan AW, Markovic N, Vana JE, Priore RL. Test-retest reliability of the cognitive lifetime drinking history. Am J Epidemiol 1997; 146(11):975-981. (Pubitemid 27524286)
23. Jernigan D. The USA: alcohol and young people today. Addiction 2005; 100(3):271-273. (Pubitemid 40363432)
24. Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3(3-4):235-241.
25. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86(9):1119-1127.
26. Rohsenow DJ, Abrams DB, Monti PM, Colby SM, Martin R, Niaura RS. The Smoking Effects Questionnaire for adult pop-ulations. Development and psychometric properties. Addict Behav 2003; 28(7):1257-1270. (Pubitemid 36952620)
27. Goldstein A, Kaizer S. Psychotropic effects of caffeine in man. III. A questionnaire survey of coffee drinking and its effects in a group of housewives. Clin Pharmacol Ther 1969; 10(4):477-488.
28. Goldstein A, Kaizer S, Whitby O. Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. Clin Pharmacol Ther 1969; 10(4):489-497.
29. Agresti A, Coull BA. Approximate is better than "exact" for interval estimation of binomial proportions. The American Statistician 1998; 52(2):119-126.
30. Parks MH, Dawant BM, Riddle WR, Hartmann SL, Dietrich MS, Nickel MK, Price RR, Martin PR. Longitudinal brain metabolic characterization of chronic alcoholics with pro-ton magnetic resonance spectroscopy. Alcohol Clin Exp Res 2002; 26(9):1368-1380.
31. Wilsnack RW, Vogeltanz ND, Wilsnack SC, Harris TR, Ahlstrom S, Bondy S, Csemy L, Ferrence R, Ferris J, Fleming J, Graham K, Greenfield T, Guyon L, Haavio-Mannila E, Kellner F, Knibbe R, Kubicka L, Loukomskaia M, Mustonen H, Nadeau L, Narusk A, Neve R, Rahav G, Spak F, Teichman M, Trocki K, Webster I, Weiss S. Gender differences in alcohol consumption and adverse drinking consequences: cross-cultural patterns. Addiction 2000; 95(2):251-265. (Pubitemid 30111246)
32. Dawson DA, Archer L. Gender differences in alcohol consumption: effects of measurement. Br J Addict 1992; 87(1):119-123.
33. King A, Epstein A, Conrad M, McNamara P, Cao D. Sex differences in the relationship between alcohol-associated smoking urge and behavior: a pilot study. Am J Addict 2008; 17(5):347-353.
34. Klesges RC, Ray JW, Klesges LM. Caffeinated coffee and tea intake and its relationship to cigarette smoking: an analysis of the Second National Health and Nutrition Examination Survey (NHANES II). J SubstAbuse 1994; 6(4): 407-418.
35. Swanson JA, Lee JW, Hopp JW. Caffeine and nico-tine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict Behav 1994; 19(3): 229-256. (Pubitemid 24182544)
36. Nestler EJ. Is there a common molecular pathway for addic-tion? NatNeurosci 2005; 8(11):1445-1449. (Pubitemid 41573654)
37. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 2000; 393(1-3):295-314. (Pubitemid 30193428)
38. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005; 162(8):1403-1413. (Pubitemid 41105554)
39. Nehlig A, Boyet S. Dose-response study of caffeine effects on cerebral functional activity with a specific focus on depen-dence. Brain Res 2000; 858(1):71-77. (Pubitemid 30105784)
40. Di Chiara G. Drug addiction as dopamine-dependent asso-ciative learning disorder. Eur J Pharmacol 1999; 375(1-3): 13-30. (Pubitemid 29317589)
41. De Luca MA, Bassareo V, Bauer A, Di Chiara G. Caffeine and accumbens shell dopamine. J Neurochem 2007; 103(1): 157-163. (Pubitemid 47404218)
42. Acquas E, Tanda G, Di Chiara G. Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats. Neuropsychopharmacology 2002; 27(2):182-193. (Pubitemid 34686970)
43. Goldman D, Oroszi G, Ducci F. The genetics of addic-tions: uncovering the genes. Nat Rev Genet 2005; 6(7): 521-532.
44. Goldstein A, Kalant H. Drug policy: striking the right balance. Science 1990; 249(4976):1513-1521.
45. Bebbington PE. The efficacy of Alcoholics Anonymous: the elusiveness of hard data. Br J Psychiatry 1976; 128:572-580.
46. Huerta M, Chodick G, Balicer RD, Davidovitch N, Grotto I. Reliability of self-reported smoking history and age at initial tobacco use. Prev Med 2005; 41(2):646-650. (Pubitemid 40732382)
47. Parra GR, O'Neill SE, Sher KJ. Reliability of self-reported age of substance involvement onset. Psychol Add Beh 2003; 17(3):211-218. (Pubitemid 37153095)
48. Johnson TP, Mott JA. The reliability of self-reported age of onset of tobacco, alcohol and illicit drug use. Addiction 2001; 96:1187-1198. (Pubitemid 32738397)